Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma

Blood. 2016 May 12;127(19):2355-6. doi: 10.1182/blood-2016-01-694786. Epub 2016 Mar 28.
No abstract available

Publication types

  • Clinical Trial, Phase I
  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anilides / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Neoplasm Recurrence, Local / drug therapy*
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyridines / therapeutic use*
  • Receptor Protein-Tyrosine Kinases / antagonists & inhibitors*

Substances

  • Anilides
  • Protein Kinase Inhibitors
  • Pyridines
  • cabozantinib
  • Receptor Protein-Tyrosine Kinases